POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Fredereick Wright
Wow,this is exciting for some say that the pipe line of new drugs is slowing, but one can be assured that as long as 18 billion dollars plus a year is coming from the USA treasury for AIDS' care, then companies like Johnson and Johnson will be in the mix to get a new piece of the market. One might, also note that this is why Tebotec has a board member on The AIDS Institute,for He can make sure that the Washington Non Profit Think Tank can help rilpivirine apear on the Medicaid,ADAP forulary.$$$
August 3, 2010 • Tampa